230 related articles for article (PubMed ID: 17666645)
1. Trastuzumab use for metastatic breast cancer in pregnancy.
Sekar R; Stone PR
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
[TBL] [Abstract][Full Text] [Related]
2. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.
Watson WJ
Obstet Gynecol; 2005 Mar; 105(3):642-3. PubMed ID: 15738038
[TBL] [Abstract][Full Text] [Related]
3. Treatment of breast cancer with trastuzumab during pregnancy.
Pant S; Landon MB; Blumenfeld M; Farrar W; Shapiro CL
J Clin Oncol; 2008 Mar; 26(9):1567-9. PubMed ID: 18349415
[No Abstract] [Full Text] [Related]
4. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
Beale JM; Tuohy J; McDowell SJ
Am J Obstet Gynecol; 2009 Jul; 201(1):e13-4. PubMed ID: 19398090
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.
Fanale MA; Uyei AR; Theriault RL; Adam K; Thompson RA
Clin Breast Cancer; 2005 Oct; 6(4):354-6. PubMed ID: 16277887
[TBL] [Abstract][Full Text] [Related]
6. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
Bader AA; Schlembach D; Tamussino KF; Pristauz G; Petru E
Lancet Oncol; 2007 Jan; 8(1):79-81. PubMed ID: 17196514
[No Abstract] [Full Text] [Related]
7. A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.
Mandrawa CL; Stewart J; Fabinyi GC; Walker SP
Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):372-6. PubMed ID: 21806575
[TBL] [Abstract][Full Text] [Related]
8. Use of pertuzumab and trastuzumab during pregnancy.
Yildirim N; Bahceci A
Anticancer Drugs; 2018 Sep; 29(8):810-813. PubMed ID: 30110018
[TBL] [Abstract][Full Text] [Related]
9. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
[TBL] [Abstract][Full Text] [Related]
10. [A long survival of a patient with poor performance status who suffered from advanced right breast cancer with multiple lung metastases controlled by trastuzumab as a key drug].
Fujikawa T; Mukai K; Tanaka A; Abe T; Yoshimoto Y; Tada S; Maekawa H; Shimoike N; Tanaka H; Kawashima T; Yokota T
Gan To Kagaku Ryoho; 2012 Jun; 39(6):1009-12. PubMed ID: 22705704
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab in pregnancy associated with poor fetal outcome.
Witzel ID; Müller V; Harps E; Janicke F; Dewit M
Ann Oncol; 2008 Jan; 19(1):191-2. PubMed ID: 18084047
[No Abstract] [Full Text] [Related]
12. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios.
Warraich Q; Smith N
J Obstet Gynaecol; 2009 Feb; 29(2):147-8. PubMed ID: 19274553
[No Abstract] [Full Text] [Related]
13. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.
Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
Reprod Toxicol; 2007 Jun; 23(4):611-3. PubMed ID: 17399946
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature.
Potluri V; Lewis D; Burton GV
Clin Breast Cancer; 2006 Jun; 7(2):167-70. PubMed ID: 16800979
[TBL] [Abstract][Full Text] [Related]
15. Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
Glück S; Castrellon A
Am J Ther; 2009; 16(6):585-90. PubMed ID: 19287304
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of trastuzumab without chemotherapy as a post-operative adjuvant therapy in HER2-positive elderly breast cancer patients: randomized controlled trial [RESPECT (N-SAS BC07)].
Sawaki M; Tokudome N; Mizuno T; Nakayama T; Taira N; Bando H; Murakami S; Yamamoto Y; Kashiwaba M; Iwata H; Uemura Y; Ohashi Y
Jpn J Clin Oncol; 2011 May; 41(5):709-12. PubMed ID: 21355003
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.
Untch M; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; von Minckwitz G
J Clin Oncol; 2010 Apr; 28(12):2024-31. PubMed ID: 20308670
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer.
Baselga J; Perez EA; Pienkowski T; Bell R
Oncologist; 2006; 11 Suppl 1():4-12. PubMed ID: 16971734
[TBL] [Abstract][Full Text] [Related]
19. Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.
Joensuu H; Bono P; Kataja V; Alanko T; Kokko R; Asola R; Utriainen T; Turpeenniemi-Hujanen T; Jyrkkiö S; Möykkynen K; Helle L; Ingalsuo S; Pajunen M; Huusko M; Salminen T; Auvinen P; Leinonen H; Leinonen M; Isola J; Kellokumpu-Lehtinen PL
J Clin Oncol; 2009 Dec; 27(34):5685-92. PubMed ID: 19884557
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
Marty M; Cognetti F; Maraninchi D; Snyder R; Mauriac L; Tubiana-Hulin M; Chan S; Grimes D; Antón A; Lluch A; Kennedy J; O'Byrne K; Conte P; Green M; Ward C; Mayne K; Extra JM
J Clin Oncol; 2005 Jul; 23(19):4265-74. PubMed ID: 15911866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
